United States · FDA National Drug Code directory
Nervousness - Anxiety
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55714-4783_b5abb3d5-39f4-3349-e053-2a95a90aada7
- Product NDC
- 55714-4783
- Form
- LIQUID
- Composition / generic term
- Aconitum nap., Ambra, Anacardium orientale, Arg. nit., Asafoetida, Bryonia, Chamomilla, Cimicifuga, Coffea cruda, Cypripedium, Gelsemium, Hyoscyamus, Hypericum, Ignatia, Kali phos., Nux vom., Sambucus nig., Strychninum, Theridion, Valeriana, Passiflora
- Labeler
- Newton Laboratories, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20190902
- Source listing expiry
- 20261231
Source-listed ingredients
- ACONITUM NAPELLUS — 20 [hp_X]/mL
- AMBERGRIS — 20 [hp_X]/mL
- SEMECARPUS ANACARDIUM JUICE — 20 [hp_X]/mL
- SILVER NITRATE — 20 [hp_X]/mL
- FERULA ASSA-FOETIDA RESIN — 20 [hp_X]/mL
- BRYONIA ALBA ROOT — 20 [hp_X]/mL
- MATRICARIA CHAMOMILLA — 20 [hp_X]/mL
- BLACK COHOSH — 20 [hp_X]/mL
- ARABICA COFFEE BEAN — 20 [hp_X]/mL
- CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT — 20 [hp_X]/mL
- GELSEMIUM SEMPERVIRENS ROOT — 20 [hp_X]/mL
- HYOSCYAMUS NIGER — 20 [hp_X]/mL
- HYPERICUM PERFORATUM — 20 [hp_X]/mL
- STRYCHNOS IGNATII SEED — 20 [hp_X]/mL
- DIBASIC POTASSIUM PHOSPHATE — 20 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED — 20 [hp_X]/mL
- SAMBUCUS NIGRA FLOWERING TOP — 20 [hp_X]/mL
- STRYCHNINE — 20 [hp_X]/mL
- THERIDION CURASSAVICUM — 20 [hp_X]/mL
- VALERIAN — 20 [hp_X]/mL
- PASSIFLORA INCARNATA FLOWERING TOP — 11 [hp_X]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 mL in 1 BOTTLE, GLASS (55714-4783-1) · 55714-4783-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →